These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 10579456)
1. Oncostatin M: signal transduction and biological activity. Gómez-Lechón MJ Life Sci; 1999; 65(20):2019-30. PubMed ID: 10579456 [TBL] [Abstract][Full Text] [Related]
2. Oncostatin M, a multifunctional cytokine. Tanaka M; Miyajima A Rev Physiol Biochem Pharmacol; 2003; 149():39-52. PubMed ID: 12811586 [TBL] [Abstract][Full Text] [Related]
3. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation. Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280 [TBL] [Abstract][Full Text] [Related]
4. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M. Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310 [TBL] [Abstract][Full Text] [Related]
5. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells. Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575 [TBL] [Abstract][Full Text] [Related]
6. Oncostatin M: a pleiotropic cytokine in the central nervous system. Chen SH; Benveniste EN Cytokine Growth Factor Rev; 2004 Oct; 15(5):379-91. PubMed ID: 15450253 [TBL] [Abstract][Full Text] [Related]
7. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells. Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359 [TBL] [Abstract][Full Text] [Related]
8. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. Thoma B; Bird TA; Friend DJ; Gearing DP; Dower SK J Biol Chem; 1994 Feb; 269(8):6215-22. PubMed ID: 8119965 [TBL] [Abstract][Full Text] [Related]
9. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130. Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060 [TBL] [Abstract][Full Text] [Related]
10. Oncostatin M regulates eotaxin expression in fibroblasts and eosinophilic inflammation in C57BL/6 mice. Langdon C; Kerr C; Tong L; Richards CD J Immunol; 2003 Jan; 170(1):548-55. PubMed ID: 12496442 [TBL] [Abstract][Full Text] [Related]
11. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Stahl N; Boulton TG; Farruggella T; Ip NY; Davis S; Witthuhn BA; Quelle FW; Silvennoinen O; Barbieri G; Pellegrini S Science; 1994 Jan; 263(5143):92-5. PubMed ID: 8272873 [TBL] [Abstract][Full Text] [Related]
12. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism. Hui W; Bell M; Carroll G Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300 [TBL] [Abstract][Full Text] [Related]
13. Oncostatin M. Bruce AG; Linsley PS; Rose TM Prog Growth Factor Res; 1992; 4(2):157-70. PubMed ID: 1338575 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells. Kasza A; Rogowski K; Kilarski W; Sobota R; Bernas T; Dobrucki J; Travis J; Koj A; Bugno M; Kordula T Biochem J; 2001 Apr; 355(Pt 2):307-14. PubMed ID: 11284716 [TBL] [Abstract][Full Text] [Related]
15. Menstrual cycle-specific inhibition of endometrial stromal cell proliferation by oncostatin M. Ohata Y; Harada T; Fujii A; Yoshida S; Iwabe T; Terakawa N Mol Hum Reprod; 2001 Jul; 7(7):665-70. PubMed ID: 11420390 [TBL] [Abstract][Full Text] [Related]
16. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor. Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570 [TBL] [Abstract][Full Text] [Related]
17. Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells. Godoy-Tundidor S; Hobisch A; Pfeil K; Bartsch G; Culig Z Clin Cancer Res; 2002 Jul; 8(7):2356-61. PubMed ID: 12114440 [TBL] [Abstract][Full Text] [Related]
18. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily. Hirano T; Matsuda T; Nakajima K Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593 [TBL] [Abstract][Full Text] [Related]
19. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies. Murakami-Mori K; Taga T; Kishimoto T; Nakamura S J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807 [TBL] [Abstract][Full Text] [Related]
20. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Gearing DP; Comeau MR; Friend DJ; Gimpel SD; Thut CJ; McGourty J; Brasher KK; King JA; Gillis S; Mosley B Science; 1992 Mar; 255(5050):1434-7. PubMed ID: 1542794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]